Goldman Sachs Group Inc Evotec Se Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Evotec Se stock. As of the latest transaction made, Goldman Sachs Group Inc holds 61,118 shares of EVO stock, worth $271,363. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,118
Previous 57,141
6.96%
Holding current value
$271,363
Previous $208,000
22.12%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EVO
# of Institutions
26Shares Held
2.91MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.3MShares$10.2 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT230KShares$1.02 Million0.54% of portfolio
-
Morgan Stanley New York, NY126KShares$559,0890.0% of portfolio
-
Black Rock Inc. New York, NY82.6KShares$366,7350.0% of portfolio
-
Lighthouse Investment Partners, LLC Palm Beach Gardens, FL39.8KShares$176,7250.01% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.57B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...